The AAMD is the only professional organization dedicated to promoting and supporting the medical dosimetry and treatment professions. Our mission statement includes an important focus on advocacy:

  • Monitoring the healthcare landscape and informing our members of changes that may impact the medical dosimetry and treatment planning profession

One of the ways the AAMD advocates for the profession is to follow pending changes in healthcare reimbursement. In July of 2019, the Centers for Medicare Medicaid Services (CMS) announced a proposed radiation oncology payment model that will likely have an impact on a large number of clinics and radiation oncology professionals around the country. During the comment period, the AAMD Board of Directors communicated with the leaders of ASTRO and AAPM about their specific concerns and then drafted a letter to CMS expressing AAMD’s concerns about the impact of the RO Model. The AAMD was one of over 300 organizations and individuals who submitted comments to CMS.

Read the AAMD letter to CMS.

The final details of the RO Model are expected to be announced by CMS before the end of 2019 for implementation in 2020. For more information, visit the CMS website. The ASTRO website also has more information about the RO Model.